The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
I'm reading these posts and wondering why I keep seeing the same thing
- I'll buy some more if it hits a £1
- Its bounced off £1 (yes by 1p and then fell again)
- Clearly no idea how RNS's work
You daren't crystallise your losses and instead watch it go down. You should have sold long ago.
I refer you all to my last post. Bad traders blame the market when it goes down and celebrate themselves as geniuses when it goes up .This thread is littered with the same comments about market manipulation, it'll be £3 by next week and averaging down being a sensible strategy. Save yourselves, this stock is a dog, stop defending your positions and think rationally.
Summarising the thread on here goes something like this
- when the price falls its because the market is being manipulated and its all wrong and unfair
- When it rises its because we all saw it coming and are really great investors
- Lots regret recent purchases but always somehow feel a need to mention the profit made when the price was higher
- Averaging down is the new fad and really clever
- The trading results on the 15th will super charge this stock
What if ..
- The market is in fact right , it usually is
- you are all deluded investors trying to time a reversal (which is really hard by the way) - better to wait for it to actually reverse
- the results are crap on the 15th as despite higher sales, costs are up and it still losing money hand over fist
You have been warned..
It’s just been fairly valued in an IPO - spinning out again doesn’t create short term shareholder value and leaves the existing shareholders with ingenuity which they aren’t convinced buy and didn’t buy into at the start
Hah thanks - my point really is about being wary, some big risks being taken on a quick reversal. The plan to spin off the beauty and nutrition arm is much hated by the investors who bought in just at the IPO.
Lots of chat about silly short selling and an impending bounce back but what if this is a correction. Dubious valuation of Ingenuity, lack of transparency, accounting issues and still a loss making business. Yet still valued at £3bn. Might just be a fair price.